Sign in

CIK 0001813814 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Definium Therapeutics, Inc.

Sign in to watch
Ticker
DFTX
Exchange
Nasdaq
Industry
Medicinal Chemicals & Botanical Products
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
operating
Phone
212-220-6633
Business address
ONE WORLD TRADE CENTER, SUITE 8500, NEW YORK, NY, 10007
Former names
Mind Medicine (MindMed) Inc.
  1. 4 Planned sale Chief Medical Officer sold 10,853 shares at $36.57 ($396,894)
  2. 4 Planned sale Chief Executive Officer sold 31,550 shares at $36.57 ($1,153,784)
  3. 4 Planned sale Chief Commercial Officer sold 3,097 shares at $36.57 ($113,257)
  4. 4 Planned sale Chief Legal Officer sold 14,051 shares at $36.57 ($513,845)
  5. 4 Planned sale Chief Financial Officer sold 3,377 shares at $36.57 ($123,497)
  6. 4 Option exercise Director acquired 1,086 shares (option exercise)
  7. 4 Option exercise Director acquired 1,629 shares (option exercise)
  8. 4 Grant or award Chief Medical Officer acquired 200,000 shares (grant or award)
  9. 4 Grant or award Chief Commercial Officer acquired 125,000 shares (grant or award)
  10. 4 Grant or award Chief Legal Officer acquired 125,000 shares (grant or award)
  11. 4 Grant or award Chief Financial Officer acquired 125,000 shares (grant or award)
  12. 4 Grant or award Chief Executive Officer acquired 750,000 shares (grant or award)
  13. 4 Planned sale Chief Executive Officer sold 19,023 shares at $37.94 ($721,733)
  14. 4 Grant or award Chief Executive Officer acquired 375,000 shares (grant or award)
  15. 4 Grant or award Chief Medical Officer acquired 100,000 shares (grant or award)
  16. 4 Grant or award Chief Legal Officer acquired 62,500 shares (grant or award)
  17. 4 Grant or award Chief Commercial Officer acquired 62,500 shares (grant or award)
  18. 4 Grant or award Chief Financial Officer acquired 62,500 shares (grant or award)
  19. 4 Planned sale Chief Legal Officer sold 13,008 shares at $45.03 ($585,750)
  20. 4 Planned sale Chief Financial Officer sold 3,013 shares at $45.03 ($135,675)

Page 1 of 10 · 186 filings